Ellerston JAADE Growth Fund

Tritium Partners is a private equity firm focused on buyouts of growth companies in the lower middle market. Tritium's investment approach emphasizes acquiring majority positions in profitable companies and creating long-term value through internal growth initiatives and acquisitions, with a particular focus on three core sectors: internet and information services, asset-light supply chain and logistics, and differentiated financial and business services. We also create platform companies by combining smaller businesses in order to establish a strong financial profile, a compelling service offering, and an enthusiastic customer base from which to execute on our growth strategies. Tritium targets high-growth companies with strong management team. These businesses are typically generating $2m to $15m EBITDA at the time of our investment.

Graphite Capital is a UK mid-market private equity firm focused on three core sectors: health & pharma, education, and data & tech-enabled services, investing in companies valued between £30 million and £150 million.

Genesis Capital is a leading lower mid-market private equity firm focused on the healthcare sector. We are active investors who work together with management teams to unlock growth in healthcare businesses that have the potential to be industry leaders. • Healthcare experts: We firmly believe healthcare investing is best done by healthcare specialists. We live and breathe it and stick to what we know best. • Business builders: We are business builders at heart and know what it takes to operate and grow lasting businesses. We find we get the best results are when we not only invest capital, but also our time and expertise to step-change a business's growth. • Strong partners: We are business builders at heart and know what it takes to operate and grow lasting businesses. We find we get the best results are when we not only invest capital, but also our time and expertise to step-change a business's growth.

US private equity firm founded in 2023 investing in lower-middle-market consumer brands, partnering with leaders to build powerful brands that make beloved products.

Emigrant Capital provides long-term equity and equity-like capital to mid-market businesses in the United States. We focus on cash flow positive businesses generating $2 to $12 million EBITDA, although we also can participate in selective turnaround opportunities. We invest in both minority and majority equity positions. Emigrant Capital is the private equity arm of Emigrant Bank, the largest family owned bank in the United States.

Archer Capital specialises in mid-market leveraged buyouts and is currently investing Archer Capital Fund 5. Archer Capital Fund 5 seeks mid-market LBO opportunities in Australia and New Zealand, favouring businesses with the opportunity to invest $75 million of equity or higher. Archer Capital considers an active partnership with management throughout the lifecycle of an investment as an essential foundation for success. We acquire companies in equity partnership with management, either the incumbent management team or a buy-in team. We assist managers to acquire or expand businesses by providing capital and, just as importantly, we actively support those managers to grow the value of their businesses and ultimately to realise that value. We bring operational expertise to our portfolio companies as well as financial and strategic capability. The quality of a business is the key to the success of a transaction. Our expertise lies in identifying potential investment opportunities with businesses in a strong market position and/or with growth potential, with strong cash flows and significant opportunities to improve operational performance. Ultimately, our skill lies in increasing and realising the value of a business. In April 2018, Archer Capital announced it would be winding up its operations.